Tananbaum James B.
Related Filers (25)
- Foresite Capital Management II, LLC (29)
- Foresite Capital Fund II, L.P. (29)
- Foresite Capital Management III, LLC (23)
- Foresite Capital Fund III, L.P. (23)
- AERIE PHARMACEUTICALS INC (20)
- Foresite Capital Management IV, LLC (15)
- Foresite Capital Fund IV, L.P. (15)
- Foresite Capital Management V, LLC (14)
- Foresite Capital Fund V, L.P. (14)
- PARDES BIOSCIENCES, INC. (12)
- Foresite Capital Management I, LLC (10)
- Foresite Capital Fund I, L.P. (10)
- Foresite Capital Opportunity Management V, LLC (9)
- Foresite Capital Opportunity Fund V, L.P. (9)
- 10x Genomics, Inc. (8)
- Kinnate Biopharma Inc. (7)
- Aimmune Therapeutics, Inc. (5)
- Gemini Therapeutics, Inc. /DE (5)
- Theseus Pharmaceuticals, Inc. (3)
- AMBIT BIOSCIENCES CORP (2)
- Quantum-Si Inc (2)
- Aclaris Therapeutics, Inc. (2)
- FS Development Holdings II, LLC (2)
- Intellia Therapeutics, Inc. (1)
- FS Development Holdings, LLC (1)
- Show More ...
Ownership (67)
4
Thursday, 8/31/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/5/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 6/13/2022
Theseus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/10/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/10/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 12/30/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/6/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Quantum-Si Inc: Statement of changes in beneficial ownership of securities
3
Monday, 6/14/2021
Quantum-Si Inc: Initial statement of beneficial ownership of securities
4
Tuesday, 2/23/2021
FS Development Corp. II: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/16/2021
FS Development Corp. II: Initial statement of beneficial ownership of securities
3
Wednesday, 2/10/2021
Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/2/2020
Kinnate Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Monday, 10/19/2020
FS Development Corp.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 8/19/2020
FS Development Corp.: Initial statement of beneficial ownership of securities
3
Tuesday, 8/11/2020
FS Development Corp.: Initial statement of beneficial ownership of securities
4
Thursday, 5/14/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/8/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/24/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/15/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/26/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/19/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2020
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 12/23/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/5/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/18/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/12/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 11/5/2019
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Monday, 9/16/2019
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/11/2019
10x Genomics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 9/6/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/4/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 8/23/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/20/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/14/2019
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 8/14/2019
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/31/2017
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 5/31/2017
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 10/11/2016
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4/A
Friday, 10/7/2016
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 10/7/2016
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3/A
Friday, 10/7/2016
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Friday, 8/19/2016
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/26/2016
AERIE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/26/2016
AERIE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Thursday, 6/2/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/5/2016
Intellia Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/26/2015
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/11/2015
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/5/2015
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/16/2013
AMBIT BIOSCIENCES CORP: Initial statement of beneficial ownership of securities
4
Wednesday, 10/16/2013
AMBIT BIOSCIENCES CORP: Statement of changes in beneficial ownership of securities